AB42. Metabolic evaluation for urinary stone disease

Urinary stone disease affects up to 15% of people globally. The etiology of stones may range from nutrition to behavior to genetics. After a first time occurence of a sympomatic stone, up to 50% of patients may experience another stone within 5 years. Thus, metabolic evaluation for the prevention of stone recurrence can play a major role in reducing the morbidity associated with urinary stones. This session will focus on the means by which we evaluate our nephrolithiasis patients and counsel them based on these results.